# Monitoring Pain Management in Veterinary Patients: A Structured Approach


## Key Takeaways

- Pain assessment in nonverbal veterinary patients necessitates a multimodal approach integrating validated species-specific behavioral pain scales (e.g., Glasgow Composite Measure Pain Scale, Feline Grimace Scale), serial physiological variable monitoring (heart rate, respiratory rate, blood pressure, temperature), and response to analgesic intervention.
- Physiological variables are most informative when trending over time; persistent elevations warrant investigation, and their interpretation must account for concurrent drug administration (e.g., alpha-2 agonists causing initial hypertension) and potential confounding factors like hypoglycemia.
- Masked pain due to opioid-induced sedation requires careful assessment of response to stimulation, as profound quietness may indicate comfort or over-sedation, necessitating evaluation of mentation and reaction to gentle handling.
- Monitoring intervals should be explicitly defined based on patient stability, drug class (e.g., opioids require reassessment within 30-60 minutes of administration), and patient factors (e.g., hepatic/renal impairment), with critical patients requiring more frequent assessments.
- Distinguishing inadequate analgesia from adverse drug effects (e.g., dysphoria mimicking pain) or disease progression is crucial, employing discriminating checks such as response to palpation of the affected region or a trial of sedation for suspected dysphoria.
- Documentation of pain scores, physiological parameters, analgesic administration, and response is essential for tracking patient trajectory, facilitating team communication, supporting clinical decision-making, and fulfilling welfare and regulatory obligations.

---

Pain is a complex, multidimensional experience that complicates objective measurement in nonverbal patients. Veterinary clinicians must therefore rely on a combination of behavioral observation, physiological variables, and response to analgesic intervention. This article provides a structured framework for monitoring pain and analgesic efficacy across canine, feline, and other companion animal patients. It is written for veterinary students and practitioners who need a defensible, repeatable method for assessing whether a patient's analgesic plan is working, when to escalate therapy, and when to investigate causes of apparent analgesic failure.

The clinical question this article answers is direct: how does the clinician know that a patient is comfortable, and how does the clinician distinguish inadequate analgesia from drug adverse effects, disease progression, or nonpainful distress? The approach presented here integrates validated pain scoring instruments, serial physiological assessment, and a structured decision pathway for analgesic adjustment. Specific drug protocols and dosing are excluded, the focus is on monitoring logic and interpretation.

## At a Glance

| Parameter | What to Monitor | Clinical Decision Point |
|---|---|---|
| Behavioral pain score | Validated species-specific composite scale | Score above intervention threshold triggers analgesic escalation |
| Physiological variables | Heart rate, respiratory rate, blood pressure, temperature | Trending matters more than single values, persistent elevation warrants investigation |
| Sedation level | Response to handling, posture, mentation | Excessive sedation may mask pain expression or indicate drug accumulation |
| Appetite and grooming | Voluntary eating, grooming behavior | Return of normal behaviors correlates with improved comfort |
| Palpation response | Reaction to gentle palpation of surgical site or affected region | Focal withdrawal or guarding suggests inadequate regional analgesia |
| Gait and posture | Weight bearing, stance, willingness to move | Reluctance to bear weight indicates persistent somatic pain |
| Analgesic interval | Duration of effect after each dose | Shortening intervals suggest tolerance, disease progression, or dosing error |
| Adverse effects | Vomiting, dysphoria, constipation, respiratory depression | Distinguish drug side effects from inadequate analgesia before changing dose |

## The Physiology of Pain and Its Measurement

Pain perception begins with nociceptor activation by thermal, mechanical, or chemical stimuli. Transduction, transmission, modulation, and perception follow, and each stage offers a potential site for analgesic action and a potential target for monitoring. The clinical challenge is that the final stage, perception, is subjective and cannot be directly observed in animals. What the clinician observes is the behavioral and physiological consequence of that perception, filtered through the animal's temperament, species-specific expression, and the modifying effects of concurrent drugs.

The stress response to pain includes sympathetic activation with increased circulating catecholamines, which produces tachycardia, hypertension, and tachypnea. These variables are sensitive but not specific. A patient in pain may have normal vital signs, particularly if the pain is chronic or if opioids have been administered. Conversely, elevated heart rate in a hospitalized patient may reflect anxiety, hypovolemia, hyperthermia, or excitement instead of pain. Serial trending of physiological variables, instead of any single reading, provides the most useful information.

Behavioral expression of pain differs markedly between species. Dogs tend to vocalize, pant, pace, and seek attention. Cats more often withdraw, hide, reduce grooming, and exhibit facial tension that can be subtle. The development of composite pain scales has addressed this variability by standardizing observation across multiple domains. These instruments assign numerical scores to specific behaviors and responses, allowing repeated assessments to be compared over time.

## Validated Pain Scoring Instruments

Several composite pain scales have been published and validated for clinical use. The Glasgow Composite Measure Pain Scale, available in short form for acute pain in dogs, scores six behavioral categories including vocalization, attention to wound, mobility, and response to touch. The UNESP-Botucatu scale has been validated for both dogs and cats and includes interactive assessment components. The Colorado State University Feline Acute Pain Scale combines behavioral descriptors with facial expression images.

Each instrument has an intervention threshold. Scores above that threshold indicate that the current analgesic plan is inadequate and that escalation or modification is required. The clinician must use the same instrument consistently for a given patient, because scores from different scales are not directly comparable. Training in the use of the chosen scale is essential, untrained observers produce unreliable scores, particularly for subtle feline pain behaviors.

Scales that rely on interaction with the patient, such as response to gentle palpation of the surgical site, provide information that passive observation cannot. A patient that appears quiet and still but reacts defensively to palpation has inadequate analgesia at that site. This distinction matters clinically because a passive patient may be overlooked if only observational scoring is used.

## Physiological Monitoring and Its Limitations

Heart rate, respiratory rate, blood pressure, and body temperature should be recorded at regular intervals in patients receiving analgesic therapy. Trends across time are more informative than isolated values. A patient whose heart rate declines progressively after opioid administration and remains stable at subsequent assessments is likely comfortable. A patient whose heart rate rises between assessments, despite stable sedation, warrants re-evaluation of the analgesic plan.

Hypoglycemia can confound the interpretation of physiological monitoring. The relationship between hypoglycemia and cardiac arrhythmia has been documented in human medicine, where sympathoadrenal activation during hypoglycemic episodes lowers the arrhythmia threshold. In veterinary patients receiving intensive therapy for conditions that impair food intake, or in those with concurrent endocrine disease, blood glucose measurement should accompany physiological assessment when pain scores and vital signs diverge. The [review of hypoglycemia and cardiac arrhythmia](https://pubmed.ncbi.nlm.nih.gov/27908250/) describes mechanisms by which metabolic derangement can mimic or amplify the autonomic signs of pain.

Blood pressure measurement is valuable but must be interpreted with knowledge of the drugs administered. Opioids may cause bradycardia without hypotension. Alpha-2 agonists produce initial hypertension followed by prolonged normotension or mild hypotension. A patient receiving these drugs may have normal blood pressure despite inadequate analgesia, or elevated blood pressure from the drug itself instead of from pain.

## The Problem of Masked Pain

Analgesic drugs alter the expression of pain. Opioids provide sedation that may suppress vocalization and movement even when nociceptive input remains significant. A patient that is quiet and immobile after opioid administration may be comfortable, or may be too sedated to express pain. Distinguishing these states requires assessment of response to stimulation. A patient that rouses, interacts normally, and tolerates gentle handling is likely comfortable. A patient that remains recumbent, does not respond to voice, and reacts only to noxious stimulation may be over-sedated, and the analgesic plan should be re-evaluated.

General anesthesia and prolonged sedation have been associated with cognitive effects in animal models. A [scoping review of cognitive deficits after general anesthesia in animal models](https://pubmed.ncbi.nlm.nih.gov/36402576/) found that cognitive deficits were detected in a majority of studies, with higher frequency in older animals and after longer drug exposures. These findings suggest that recovery from anesthesia may involve cognitive slowing that complicates pain assessment in the immediate postoperative period. The clinician should allow adequate time for drug elimination before interpreting behavioral pain scores as indicative of pain instead of residual anesthetic effect.

Dysphoria is a particular challenge. Some opioids, especially in cats, produce behavioral excitation that resembles pain. The dysphoric patient may vocalize, pace, and appear distressed. Distinguishing dysphoria from pain requires careful observation of the quality of vocalization, the patient's response to gentle handling, and the temporal relationship to drug administration. If the behavior began shortly after an opioid dose and the patient does not react to palpation of the surgical site, dysphoria is more likely than pain.

## The Monitoring Interval and Its Determinants

The frequency of pain reassessment should be prescribed explicitly, not left to clinical intuition. For patients in the immediate postoperative period, reassessment every 1 to 2 hours for the first 12 to 24 hours is standard, with intervals extended to every 4 to 6 hours once scores are consistently low. Critically ill patients, those receiving continuous rate infusions, and patients with fractures or thoracic disease warrant the shorter end of this range. Patients managed with intermittent bolus analgesia should be reassessed at the expected time of peak effect and again near the end of the dosing interval, because this captures both efficacy and duration of action.

The monitoring schedule must also account for the drug class in use. Opioids require reassessment within 30 to 60 minutes of administration. Non-steroidal anti-inflammatory drugs reach peak effect more slowly, so meaningful efficacy assessment occurs at 2 to 4 hours. Multimodal regimens complicate this picture, and the schedule should be anchored to the fastest-acting component while still capturing the contribution of slower agents.

Patient status changes the interval. A patient with cardiovascular instability may have altered drug distribution and clearance, making both efficacy and adverse effects less predictable. Hepatic or renal impairment slows elimination of many analgesics, and monitoring must extend beyond the usual window. Geriatric patients and neonates metabolise drugs differently, and their pain scores should be interpreted with the awareness that age-related changes in behavior can mimic or mask pain. The evidence base for anesthetic effects on cognition in animal models is drawn largely from rodent studies, and extrapolation to clinical patients requires caution, but it supports the principle that recovery from anesthesia is not a single event and that behavioral assessment in the hours after recovery may be confounded by residual drug effects.

## Selecting the Right Tool for the Patient

No single pain scoring instrument serves every patient. The choice depends on species, the nature of the procedure or disease, the patient's temperament, and the equipment available. Composite instruments that combine behavioral and physiological items are the most practical for hospital use, but they require training and consistency among observers.

For dogs, the short form of the Glasgow Composite Measure Pain Scale is widely used and validated for acute pain. It scores six behavioral categories and produces a single numerical value with a validated intervention threshold. The Colorado State University Canine Acute Pain Scale is simpler and faster, making it suitable for busy clinical settings, but it relies more heavily on observer judgment. For cats, the UNESP-Botucatu scale and the Feline Grimace Scale are both validated, with the grimace scale offering the advantage of being applicable from photographs and requiring minimal handling.

The table below summarizes selection criteria for common instruments.

| Instrument | Species | Best Use | Key Limitation |
|---|---|---|---|
| Glasgow CMPS-SF | Dog | Acute postoperative pain, research settings | Requires training, less useful in aggressive patients |
| Colorado State Canine Scale | Dog | Rapid serial assessments in hospital | More subjective, inter-observer variability |
| UNESP-Botucatu | Cat | Acute pain, analgesic efficacy trials | Time-consuming, requires video or direct observation |
| Feline Grimace Scale | Cat | Non-contact assessment, triage | May miss visceral or neuropathic pain |
| Composite pain scales | Both | Multimodal pain, chronic pain | Not validated for all conditions |

Species differences extend beyond instrument choice. Cats mask pain more effectively than dogs, and their pain behavior is often subtle: reduced grooming, tail flicking, and changes in facial expression instead of vocalisation or lameness. Rabbits, rodents, and exotic species present greater challenges, and for many of these species validated instruments do not exist. In such cases, the clinician must rely on species-specific ethograms, knowledge of normal behavior, and physiological parameters interpreted with caution. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific guidance on pain recognition and assessment that is useful when working outside common companion animal species.

## The Assessment Sequence and Decision Points

A structured assessment should follow a consistent sequence. First, observe the patient from a distance before handling. This captures spontaneous behavior: posture, activity, interaction with the environment, and response to the presence of observers. Second, approach and interact with the patient in a standardized manner, noting response to gentle handling, palpation of the surgical site or affected region, and willingness to move. Third, record physiological parameters, but interpret them in context. Heart rate and respiratory rate are influenced by stress, excitement, and drugs, and they should never be used alone to diagnose pain.

The decision point is the intervention threshold. For instruments with validated thresholds, such as the Glasgow CMPS-SF, a score at or above the threshold indicates that analgesia should be escalated. For instruments without validated thresholds, the clinician must use a combination of score trend, physiological parameters, and clinical judgment. A rising trend across serial assessments is more informative than a single elevated score, because it suggests either worsening pain or inadequate analgesia.

When a patient's score exceeds the threshold, the response should be a structured escalation. This begins with checking that existing analgesia has been administered correctly and on time. If it has, the next step is to add a drug from a different class, increase the dose of the current drug within its licensed range, or change the route of administration. The response to rescue analgesia should be reassessed within 30 to 60 minutes for parenteral opioids and within 2 hours for other classes. Failure to respond to rescue analgesia should prompt a search for a non-pain cause of the behavior, including surgical complications, urinary retention, or delirium.

## Documenting Pain Scores and Analgesic Response

Documentation serves three purposes: it tracks the patient's trajectory, it communicates the plan to all members of the team, and it creates a record that supports clinical decisions. Each pain score should be recorded with the time, the instrument used, the observer, and the analgesic drugs administered since the previous assessment. The response to each intervention should be documented as the difference between the pre-intervention and post-intervention scores.

A standardized pain flow sheet is more useful than free-text notes. The sheet should include a column for the score, a column for physiological parameters, a column for drugs administered, and a column for the planned reassessment time. This structure makes it possible to identify at a glance whether the patient is improving, stable, or deteriorating, and whether the analgesic plan is being followed.

The monitoring record also has welfare and regulatory significance. In many jurisdictions, the veterinary practice is responsible for ensuring that pain is adequately managed, and a documented monitoring schedule demonstrates that this duty has been met. International standards for animal health and welfare, such as those published by the [World Organization for Animal Health](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/), increasingly reference pain management as a component of responsible veterinary care. Professional guidance from bodies such as the [American Veterinary Medical Association](https://www.avma.org/resources-tools) reinforces the expectation that pain assessment and monitoring are part of standard practice.

## Adjusting the Plan Based on Response

The monitoring schedule is not a fixed protocol. It is a framework that must be adjusted in response to the patient's trajectory. A patient whose pain score remains below the intervention threshold for two consecutive assessments can be moved to a longer interval. A patient whose score is rising, or who requires rescue analgesia more than twice in a 24-hour period, needs a revision of the analgesic plan instead of simply more of the same drug.

The response to rescue analgesia is itself a diagnostic test. A patient who responds promptly and completely to an opioid has pain that is likely nociceptive in origin. A patient who responds partially or not at all may have neuropathic pain, visceral pain that is poorly responsive to opioids, or a non-pain cause of distress. This distinction changes the choice of subsequent therapy and should be documented explicitly.

Adjustments must also account for adverse effects. Sedation, nausea, ileus, and respiratory depression are all possible with opioid therapy, and the monitoring schedule should include checks for these effects alongside pain scores. A patient who is pain-free but heavily sedated is not adequately managed, and the analgesic plan should be titrated to achieve comfort without excessive sedation. This balance is the central clinical skill in pain management monitoring, and it improves with consistent use of structured instruments and explicit decision rules.

## Recognized Complications and Failure Modes

Analgesic monitoring fails in predictable patterns. The most common complication is unrecognised escalation of pain despite an unchanged pain score. This occurs when the chosen instrument lacks sensitivity for the specific pain type, such as using a lameness scale for visceral pain, or when the assessor scores at the same point in the animal's rest-activity cycle each time. A dog that is painful only on weight-bearing will score normally if examined while recumbent. Detection requires varying the stimulus context during each assessment, including observation at rest, during movement, and during palpation of the suspected region.

A second failure mode is opioid-related sedation masquerading as analgesia. Sedation lowers activity and vocalisation, which many composite instruments score as comfort. The discriminating check is response to a mildly aversive stimulus, such as gentle pressure on the wound margin. A sedated but comfortable patient will rouse and may resist, a sedated patient with uncontrolled pain will show a withdrawal response out of proportion to the stimulus. Serial assessment of sedation depth using a simple scale, separate from the pain score, prevents this confusion.

Respiratory depression from systemic opioids is a recognized complication, particularly in brachycephalic breeds and neonates. Pulse oximetry and capnography detect hypoventilation before cyanosis appears. End-tidal carbon dioxide above 55 mmHg with a declining respiratory rate warrants reduction of the opioid interval or dose, with current formulary guidance consulted for the specific agent. Hypoglycemia can mimic or amplify signs of distress and has been associated with cardiac arrhythmia in human medicine, a mechanism reviewed in the context of intensive insulin therapy [hypoglycemia and cardiac arrhythmia mechanisms](https://pubmed.ncbi.nlm.nih.gov/27908250/). Blood glucose measurement is therefore part of the monitoring panel in any patient that is anorexic, neonatal, or receiving insulin.

Dysphoria is the most frequently misread complication. It presents as restlessness, vocalisation, and apparent distress that does not respond to additional analgesia. The discriminating feature is that dysphoric patients often worsen with further opioid administration and show no localizing signs of pain. A test dose of a low-dose sedative, where clinically appropriate, can distinguish dysphoria from pain: the dysphoric patient settles, while the painful patient becomes more obvious in its discomfort once sedation removes the behavioral overlay.

| Observation | Likely cause | Discriminating check |
|---|---|---|
| Pain score unchanged, patient deteriorating | Instrument insensitive to pain type | Reassess with a different validated tool and vary stimulus context |
| Low pain score with profound quietness | Opioid sedation | Assess response to gentle aversive stimulus, score sedation separately |
| Rising respiratory effort, low SpO2 | Respiratory depression | Capnography, reduce opioid interval per formulary |
| Restlessness, vocalisation, no localizing signs | Dysphoria | Trial of sedation, observe response before giving more opioid |
| Tachycardia persists despite apparent comfort | Unrecognised pain or hypovolemia | Check perfusion parameters and blood glucose, reassess pain with species-appropriate tool |

## Common Errors in Clinical Practice

Less experienced clinicians tend to score pain once and treat the number instead of the patient. The corrective action is to treat trends, not single observations. A score that rises from 2 to 4 between intervals is more clinically significant than a stable score of 6 in a patient that has been comfortable at that level since admission. Students frequently anchor on the first score they record and unconsciously adjust subsequent scores toward it. Recording the score before reviewing the previous entry, or having a second observer score independently, reduces this bias.

A second common error is applying a tool validated for one species to another without adjustment. Feline pain behavior differs markedly from canine behavior, and instruments developed for dogs will under-score cats. Use species-specific validated tools, and for exotic or production species where validated instruments are limited, rely on a combination of behavioral ethograms, physiological trends, and response to a test dose of analgesia. The MSD Veterinary Manual provides species-specific guidance on pain recognition and assessment across domestic and production species [MSD Veterinary Manual professional reference](https://www.msdvetmanual.com/).

A third error is documenting a pain score without documenting the context in which it was obtained. A score taken after the patient has been resting undisturbed for two hours is not comparable to one taken immediately after a bandage change. The assessment record must include the patient's activity state, recent interventions, and time since last analgesic administration. Without this context, serial scores cannot be interpreted and the monitoring plan loses its value.

## Limitations of the Evidence Base

The evidence base for veterinary pain monitoring is uneven. Most validated instruments exist for dogs and cats in acute postoperative settings. Chronic pain assessment, particularly for osteoarthritis and neuropathic pain, relies on owner-reported questionnaires with variable correlation to objective measures. For production species, laboratory animals, and exotic species, validated tools are sparse and expert opinion diverges on what constitutes a reliable indicator. The Davis-Thompson Foundation maintains pathology teaching resources that can help clinicians recognize lesion-associated pain, but these do not substitute for behavioral assessment [Davis-Thompson Foundation pathology resources](https://www.davisthompsonfoundation.org/).

Expert opinion differs on the value of physiological parameters. Some authorities maintain that heart rate and cortisol are useful adjuncts, others argue they are too non-specific to guide analgesic decisions. The weight of current opinion favours behavioral instruments as primary and physiological parameters as supportive, but this consensus is not universal. Where evidence is lacking, the clinician should document the rationale for the chosen approach and review it against the patient's response.

## Referral and Escalation Criteria

Referral to a specialist anesthetist or pain service is warranted when pain remains uncontrolled after two escalations of the analgesic plan, when the patient requires escalating doses to maintain the same effect, or when neuropathic pain is suspected. Specialist input is also appropriate for patients with chronic pain that has failed first-line management and for species where the clinician lacks experience in pain assessment.

Laboratory involvement is indicated when monitoring suggests a complication instead of inadequate analgesia. Rising inflammatory markers, unexplained fever, or deteriorating perfusion warrant hematology and biochemistry to exclude surgical site infection, pancreatitis, or organ dysfunction. Regulatory reporting obligations vary by jurisdiction. Where a product is suspected of causing an unexpected adverse reaction, the manufacturer and the relevant national pharmacovigilance scheme should be notified. The World Organization for Animal Health publishes international standards for animal health surveillance that may apply in production animal settings [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). Clinicians should confirm the reporting pathway applicable to their region and species.

## Frequently Asked Questions

### How Do I Monitor Pain When Only Basic Equipment Is Available?

When physiologic monitors and validated scoring tools are unavailable, structured observation becomes the primary instrument. Record behavior at rest, during handling, and after movement. Use a simple numeric scale with explicit anchors, such as 0 for no response and 3 for vocalisation or escape attempts on palpation. Palpate the suspected region last and compare with a contralateral or control site. Serial assessments by the same observer reduce inter-rater variability. Document the context of each observation, including time since analgesic administration and recent handling. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific guidance on recognizing pain-related behavior when advanced tools are not practical.

### What Is the Minimum Acceptable Frequency for Pain Scoring in Hospitalized Patients?

There is no universal standard, but a practical framework is to score every 4 hours for stable patients and every 1 to 2 hours for unstable or post-operative cases. Score before and 30 to 60 minutes after analgesic administration to judge efficacy. Patients receiving continuous infusions require at least hourly assessment of sedation and comfort. Document the time of each score relative to drug administration and procedures. If staffing limits frequency, prioritize scoring at analgesic peaks and troughs instead of at random intervals. The [AVMA practice resources](https://www.avma.org/resources-tools) offer guidance on establishing hospital protocols that balance clinical need with available personnel.

### How Does Pain Monitoring Differ in Exotic or Production Animal Species?

Validated scoring instruments exist for common companion species but are limited for exotics and livestock. In cattle, sheep, and goats, observe posture, weight shifting, tail position, and interaction with the group. In rabbits and rodents, facial expression, grooming cessation, and reduced food intake are useful indicators. Production animals often mask pain to avoid predation, so changes in feeding behavior and milk yield may be more reliable than overt responses. For herd-level monitoring, track group behavior and production parameters instead of individual scores. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) address welfare assessment frameworks applicable across species in commercial settings.

### How Should I Document Pain Scores to Support Clinical Decisions and Continuity of Care?

Record the instrument used, the numerical or categorical score, the time, the observer, and any analgesic given. Include the route and time of administration so the next clinician can assess peak effect. Use a standardized form or electronic template so trends are visible across shifts. Note any deviation from the expected response, such as a rising score despite analgesia. This documentation supports escalation decisions and provides a legal record of welfare assessment. The [Davis-Thompson Foundation](https://www.davisthompsonfoundation.org/) pathology resources illustrate how systematic documentation of clinical findings, including pain-related observations, supports diagnostic and treatment review.

### What Should I Do When a Patient's Pain Score Does Not Match Its Behavior?

Discrepancies between scores and observed behavior require investigation instead of dismissal. Reassess using a different instrument, as each tool captures different pain dimensions. Check for sedation, which can mask pain responses, or for conditions such as dysphoria that mimic pain. Consider neuropathic or visceral pain that may not respond to standard analgesics. Review the time since the last dose and whether the drug's peak effect has passed. If the discrepancy persists, perform a focused physical examination and reassess the analgesic plan. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) notes that behavioral signs of pain vary with species, age, and individual temperament, so context matters.

### How Do I Explain Inadequate Analgesic Response to an Owner or Referring Veterinarian?

Frame the discussion around objective findings instead of subjective impressions. State the pain score, the drug given, and the observed response over a defined interval. Explain that individual variation in drug metabolism and pain perception means the first choice may not be effective. Describe the next step, such as adding a different drug class or escalating the dose under formulary guidance. Avoid promising immediate resolution. Provide the owner with a written summary of the scores and the revised plan. The [AVMA practice resources](https://www.avma.org/resources-tools) include communication guidance for discussing treatment failures and adjusting care plans with clients.

## Related Clinical & Scientific Guides

* [Hypersensitivity Reactions: Types and Mechanisms](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/hypersensitivity-reactions-types-and-mechanisms)
* [Therapeutic Decision-Making for Respiratory Infections in Cattle](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/therapeutic-decision-making-respiratory-infections-cattle)
* [Monitoring Fluid Therapy in Critically Ill Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-fluid-therapy-critically-ill-veterinary)


## References and Further Reading

- [Vascular implants - new aspects for in situ tissue engineering.](https://pubmed.ncbi.nlm.nih.gov/35382534/). 2022.
- [Human rabies: still a neglected preventable disease in Nigeria.](https://pubmed.ncbi.nlm.nih.gov/25666005/). 2015.
- [Hypoglycemia and Cardiac Arrhythmia, Mechanisms, Evidence Base a nd Current Recommendations.](https://pubmed.ncbi.nlm.nih.gov/27908250/). 2017.
- [Management of anticoagulation and its reversal during pediatric cardiopulmonary bypass: a review of current UK practice.](https://pubmed.ncbi.nlm.nih.gov/10866420/). 2000.
- [Cognitive deficits after general anesthesia in animal models: a scoping review.](https://pubmed.ncbi.nlm.nih.gov/36402576/). 2023.
- [First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotransplantation.](https://pubmed.ncbi.nlm.nih.gov/26918540/). 2016.
- [Davis-Thompson Foundation Veterinary Pathology Resources](https://www.davisthompsonfoundation.org/). Davis-Thompson Foundation.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
- [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association.

## Related Articles

- [Differential Diagnosis in Pathology: A Structured Approach](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/differential-diagnosis-in-pathology-a-structured-approach)
- [Monitoring Immunosuppressive Therapy in Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-immunosuppressive-therapy-veterinary)
- [Monitoring Nutritional Support in Hospitalized Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-nutritional-support-hospitalized-veterinary)
- [Monitoring Protocols for Chemotherapy in Veterinary Oncology Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-protocols-chemotherapy-veterinary-oncology)
- [Monitoring Sedation and Anesthesia Recovery in Veterinary Patients](/knowledge/veterinary-medicine/veterinary-pathology-microbiology/monitoring-sedation-anesthesia-recovery-veterinary)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.